Results 121 to 130 of about 49,999 (280)

Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction

Revista Portuguesa de Cardiologia, 2019
Introduction: Stent restenosis remains a clinical challenge for patients with ischemic heart disease, since it is associated with repeated coronary interventions as well as higher hospitalization rates and medical costs.
Ibrahim Rencuzogullari, Yavuz Karabağ, Metin Çağdaş, Süleyman Karakoyun, Sabri Seyis, Mustafa Ozan Gürsoy, Mahmut Yesin, İnanç Artaç, Doğan İliş, İbrahim Halil Tanboğa   +9 more
doaj   +1 more source

Stent placement for renal arterial stenosis: where do we stand? A meta-analysis [PDF]

, 2000
PURPOSE: To perform a meta-analysis of renal arterial stent placement in comparison with renal percutaneous transluminal angioplasty (PTA) in patients with renal arterial stenosis.
Bosch, J.L. (Johanna), Deinum, J. (Jacob), Dijk, L.C. (Lukas) van, Gussenhoven, E.J. (Elma), Jaarsveld, B.C. (Brigit) van, Leertouwer, T.C. (Trude), Man in 't Veld, A.J. (Arie)   +6 more
core   +1 more source

PRECLINICAL EVALUATION OF THE VASCULAR EFFECTS OF REJUVENATE® COBALT CHROMIUM CORONARY STENT SYSTEM IMPLANTED IN THE PORCINE CORONARY IN STENT RESTENOSIS MODEL

, 2021
Murtaza Najabat Ali, Mariam Mir, Piotr Buszman   +2 more
openalex   +2 more sources

Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications [PDF]

, 2023
Daniele Giacoppo, Jorge Saucedo, Bruno Scheller   +2 more
openalex   +1 more source

Evaluation of Off‐Label Postoperative Inhaled Steroid Use in Tracheal and Cricotracheal Resection

Otolaryngology–Head and Neck Surgery, Volume 174, Issue 2, Page 473-478, February 2026.
Abstract Objective Tracheal resection (TR) and cricotracheal resection (CTR) are associated with anastomotic complications. Off‐label use of inhaled corticosteroids has gained popularity for reducing tracheal granulation tissue, though adoption remains limited due to unclear safety and efficacy.
Jason Shin Chwa, Alexander Tu Hong, Elizabeth Ann Shuman, Karla O'Dell   +3 more
wiley   +1 more source

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

Clinical and Applied Thrombosis/Hemostasis
This study aimed to evaluate the safety and efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) and stenting for treating acute iliofemoral deep venous thrombosis (DVT) combined with iliac vein compression syndrome (IVCS), and to ...
Lin Zhang MM, Chuli Jiang MD, Zheng Chen MD, Wei Song MD, Yu Zhao MD, PhD, Fenghe Li MD, PhD   +5 more
doaj   +1 more source

In-stent restenosis.

Cardiovascular therapeutics, 2011
The introduction of coronary stents marked a major turning point in the practice of interventional cardiology. Whereas the efficacy of balloon angioplasty was challenged both by immediate mechanical complications and by a high incidence of restenosis, coronary stents offered cardiologists a means by which to not only augment immediate procedural ...
Michael S, Kim, Larry S, Dean
openaire   +1 more source

Quantifying stent‐induced dose perturbations in intravascular brachytherapy using 3D‐ printed phantoms and film dosimetry

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background Coronary artery disease (CAD), the leading cause of death worldwide, is the narrowing of coronary arteries due to atherosclerotic plaque buildup. A common treatment for CAD is percutaneous coronary intervention (PCI), often involving stent placement. However, a common complication or in‐stent restenosis (ISR) can occur in 10%–20% of
Jessica S. Jung, Lyu Huang, Nicholas Coupera, Yijian Cao, Jenghwa Chang   +4 more
wiley   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

European Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli, Stefano Fumagalli, Tiziana Cristina Minopoli, Silvia Menale, Valentina Scheggi, Niccolò Marchionni   +5 more
doaj   +1 more source

Ultrafine Molybdenum Wire Braided Neurointerventional Implants: Bridging Biodegradability and Neurovascular Safety for Stroke Treatment

Advanced Science, Volume 13, Issue 1, 5 January 2026.
Molybdenum (Mo), with its unique strength, uniform corrosion, and radiopacity, enables innovative biodegradable implants for transformative stroke therapy. Abstract Neurovascular implants for stroke intervention face a critical dilemma: permanent devices (e.g., nitinol stents, platinum coils) often trigger chronic inflammation and recurrence, whereas ...
Yunong Shen, Yiming Huang, Yang Zhang, Chunhao Yu, Hanqi Liu, Dong Bian, Di Wu, Wu Wang, Xunming Ji, Yufeng Zheng, Miaowen Jiang, Ming Li   +11 more
wiley   +1 more source